[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"153c74d1f74d8bb460562d01523b51c58256ff8438a9c29345a681da97ff38b3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"153c74d1f74d8bb460562d01523b51c58256ff8438a9c29345a681da97ff38b3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"20261014T203208-0851c9a1","semester":"1274","observed_at":"2026-10-14 17:50:09.728220+00:00","record_version_id":"17f4c1fe83174336f75e3de8cf7e5921c78fcb15ac19df225507f9876d0faca6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"85c509167a35114b737372ef2a1003f13cc2dbea3ba5e3e3dfaf169d51c17e38","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Interpret and integrate ECG manifestations of metabolic causes of cardiac arrest and the non-shockable rhythms.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Summarize the fundamental mechanisms of cardiac electrophysiology.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Relate electrical signaling and neurohormonal regulation to cardiac function.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Interpret and integrate ECG manifestations of basic mechanisms of cardiac arrhythmias.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Interpret and integrate ECG manifestations of inherited arrhythmia syndromes.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Compare and contrast basic mechanisms and ECG manifestations of inherited arrhythmia syndromes.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Correlate the mechanisms of antiarrhythmic drugs with their effect on cardiac action potential.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Interpret and integrate ECG manifestations of antiarrhythmic toxicity.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Articulate the basic underpinnings and indications for catheter ablation.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Articulate the basic underpinnings, indications for, and ECG manifestations of cardiac pacemakers and implantable cardioverter-defibrillators.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Evaluate arrhythmias and therapeutic modalities of patients in the presenting to electrophysiology clinic.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Research how arrhythmias are studied in the basic science setting.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:27.872187+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/medicine/\",\"term\":null,\"text\":\"Categorize antiarrhythmic medications according to their appropriate use.\"}]"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"e3c6918fda47581e2f044b07de39270f7d0a73373f6848d8fc53c0d28a6a01e4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"e3c6918fda47581e2f044b07de39270f7d0a73373f6848d8fc53c0d28a6a01e4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"93d172572562b3b51275d0761ad069d71b42655c2588ba1a3e14b6f1ac40926e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"a1c313cde3924b05fe98b742715444ddd782bd7a9cc39f91030b8d572d5854ad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"8d6f7afca372747ba736af4854ac502c2b8d4fd98a466be735cb5a6fab96d7c6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"bb0678d85a8d4d7f88c8788e846fb13c009f44bfaa2ed79114402b6e6c3749c7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"9d5ec46115ef8d8b042ed5f53b33e03bcb33625a0742ba874fa71512a5a9ba7e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"dc7f58107f4c31c3f9d10bee7fd0777b90783537bd57cdb463e1f5288ae0a24b","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"bd077020674a76d7eda8051baeb7d3d6bcf6dd8d8a7498203f2e19ed07cea43e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"eaa14f2603dda357b82646527e941cfcd5af0ef0944ac27aca59e9536289b5f7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"038aa31ba7ee9ac8bde7be0d2dbd02186685f2545f991fdf9cf8cec21a8d7ec8","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"16522a7fc2bfafb04387cfcde8e75993661b9844b3440fec9227ed7a965533ad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"4b0aca327863b56f3c12dee29118dd1a3a67440fc75f717ba4ed863c439ac132","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"a13cbd4dcfdcef65585b979fbde6e718c8b54bf7de8e2b2469624d40b69cc6f2","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"293f8e7c62a1a59592b349061315750546f7f852a0fea6eaeab14d8d252e7320","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"e6a16302944a7cd0fe188ab76fdd5bbe46ae03133dbf74e998876f91990405b6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"88283756541567081c70f24ca8b222c1120a14196a981f2eaf80a69fa8b5c0a1","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"e5703735acd0975e31a9679df194e7c773dac4332a741c12a80dfea20190da7e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"b93503c5397ce751ae7d243190744906a43f7d43ef19a7697a38308bec2da327","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"91f1f6bd3b7b052263eed56f86c3a599e372bea0c667f11cdf7c6ffd58c45680","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"cedb36e3661d9de47fbe592f5fae02887b11c3432ef896417b9e1c533027a7c3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"70783a232c70ab6ce48b433a7f0bbb99118f24424c720710e33868cbae323c01","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"477ae091611bb45da30d5ae8f317f2850ad6a7364c0c2b392c2dda07ebfbd483","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"c7f0f721a3b5fcce231e8354b9c95e3b5236669e46499a84f4d113b020ac20ad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"98c044bb2ad47493076fe80ec25696fe8298e5433be058e196c7f13e0cce0062","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"a42f2de9478248a28aefa3a9a446605438670e81abaf24f5a453dd0155cddbf7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"b96f7cb1b3dae96f2d5ba6cb00d56941743ed46d6e79c6771a344111373f9471","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"1b37a582c6088d1b61cf751129ac56e31765e8b6ddea70e3fc40c6b041a003d2","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"d2705d0f9efffce49b699c2cc107a975ffc6da0def28482fb4b411217c85ec24","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"2bb340c0167e1bc3d31945587884486bc2b4c6ad72ba9739b74b65b8a351b477","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"08186c53aba5d773b94fb1b37099b907a7a35d87f2fec5111d2a0ef18aafaf97","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"12a5981c11613721b7a951604c537c7f0272edb9a5528d5bdf9d1255c2514896","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"4358a0e882c64fa4afff26d41da1b22b7aa3a3ac947a03b0fad04570fcd2fb7b","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"57ae9dccfcde86078de07d6e0883979979cdc0158f1871b16e68513b82b735c3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"02939dbd5436248e07f4dae2cb2bea1ba0a76ca4c30ea568a1b9351e6b5b87a5","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"a9d1df17772b227b7d33046c074f7808b7c4c02c61b0a4a37d9f53c42e8c1372","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"435a8d4346742d3f1c01b1770c47e6acfa98285462850dcba9ad3016f052e5b3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"0cdf6246deed0ee5ceb6659ef0339c8c13f421c96736d9fcaccd2cedd1785a29","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"04a224592819478ed0164159f16c37bfd914dc04fc63b6273666771e4f4cf0b5","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"31f646925a301cfbc562995add69c0b4a04b170bbc1413c05db1b62759663bee","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"0b095f7f157b8a037a4fd486403949c6cc62d6607afbb36dc04815f368ebc2fa","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"1c3b302b9899f4658ca84a90511f05d163c683841f572789df0f7eb0699cb863","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"af9ccda69b951ddc8102c6fe05d15726bc572251896d90bb628e563330f73b98","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"3ec8b3dbed50c41b989d23313f5cbd4861f463d497fd8aadc29dc35ea88e590e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"c67d68b7ae81e4b37264dbe134f809f28e6af4cfe4bc9ff63a07e0a4ddc18a31","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"4c8bbf7d6aa2528c7ada81b8110a410140f93491da95c1b0f188f1bdbc85bfb4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"b9ead40cafbf6b660cba83ba0e4bf35a7df21dacf1c6147310ce51dbbad6ff2e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"6d0b0bf0d4c6308b08479b7dea273cc3f909a753f5d283f2c73728c93751ca9a","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"1890bb42fdbf41d7e93bcd324642bf8be9c7c198af2a75fd54f53c0b1e5e9ed9","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"63f962d97da358a19622d2ce50716df31396809d2b339c4274f833dfddb78fe6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"747d64c41f9c7538c89261b31a4feb058e757ad2e8e22674897b09560d5ab160","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"d5f2e5f199081147374e8178d47a70ebd5838d42f9d6cb549aacc80ca292a6d3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"ac230b5f8dd882f989c4ed5d4d3d09d31c9aab96f64310718096939891636a07","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"8510ab2c6fcce8b6ea2bdecefde591dc629370ca915015acd775140602c620c3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"6d090ca996327da2bb9d9c43ee244d7f6b04306c308e2ae337924af638eac220","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"6844bb6958c2067068eb84aaba30b645a0ce994b60ac54d4b68cee954b5efce9","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"3ad152cceb70efd165edb928ce7774d37d0bfab3bca7a2246c2678dec40e9a22","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"58db1ffa27bd4f1d96146b14c236aa2e4f3b9859bf1caa643c815f3e0e816274","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"70e42232736fc2a5bbc6c745e5bd0c63e98e319b72bca9f351b8981b0d0b992e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"aa3b21f659447519e9745683f3e8d27aa2a5dff3ee1872a0c3b2e4b895094a54","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"1e58bfecb00f619943eba40677b5a33fdd1caa3a2100a04312f66de30f2299ee","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"f9c5ccda53371246758020ba904cd011bcb5b24df3baf54addc5eb5869e5a3d3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"2c1e9f0195572f2cef2e9c299f3e995ba1746f89a2ed25831eca748762763af7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"4af84b1b5e80b2d91dfaec75e4bcc72ac44520dd779b34bd23420c43565b8dad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"c67d68b7ae81e4b37264dbe134f809f28e6af4cfe4bc9ff63a07e0a4ddc18a31","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"bb630fd8b22c93c12bbaac53288bfc46fab6d5858e673de13ae23a075d1fefc4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"2b061a5b1e6ee5d1da1ba4c57bb66ef9368463d71ecdc52a233e356c26383f1c","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"11cd3204e96e6cb91c948ebf9373328ec1feeb892b07fe9bc5166cc71ac71a63","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"0cfb2a4c1ff6ba37236e063436cdcd0006c01e85f42e315ccaafd697d905ac38","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"13d38932cf642c783b76a664ed0e0f72537b95dd20ec4f2c4c6b494cf3a7c8a6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"ce2c15c4601e8c26489dddfa8f2e0cbafe43ac0f441c65e8059b9f3366b5c2a8","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"05714c2fb77219d4f03d34eadae876aaf1ce7ef2325e33b917bee8be701aa40e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"41f24a4111609a9618bfdadccd3eb167e329b555f435b00f36c669dce57241fa","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"ad06978e3f51e67183aedd7d8776fe6710569780f1d37184ea1e80809df1778b","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"56f8c93abafb4c5453ecb4b6edad586fbc21eec4476408ce82bfa8b0008f73a7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"052cbcf263ff2b2da73941cc08f63ffefc4a35a2bfa830a059e6ea5f149f72fa","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"59ee310a3c96a05e711bdc27d4d4c24399d5f0396310f88111f7b686b4ea7515","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"af4b232e193091b878f52877642c05afffa2b31abff61489b1641ffd4211b420","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"6170ab16d697ad5a02e4d2b784295899ff27a63efbb0d99595df22aa418ea431","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"0cfa0454cc4a15e600b3f4ee6e553c91b969cb194149da139a320ef9e61cccc3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"ccea5b30793be60faa7feb2a9453c2889fd05c77a43dd9489347bb59a3810422","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"981b8f71d4bbc4293c29bf3e441dd7a4095bd21f5ab95f7861131e6aafee3e1d","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"}]